Get the Daily Brief
Latest Biotech News
Deep Visual Proteomics Unlocks Treatment Pathways for Toxic Epidermal Necrolysis
A Max Planck Institute team applied deep visual proteomics, combining imaging, machine learning, and mass spectrometry, to analyze toxic epidermal necrolysis (TEN) at a spatial proteome level....
Mass Spectrometry Maps Protein Localization Changes in Viral Response
Scientists at Chan Zuckerberg Biohub developed a mass spectrometry–based method to spatially map the subcellular localization of proteins, revealing dynamic relocalization during viral infection....
Advanced AI Enables Synthetic Proteins Outperforming Natural Genome Editors
Researchers at Integra Therapeutics along with Pompeu Fabra University and the Center for Genomic Regulation have designed synthetic proteins via generative AI that exceed natural proteins in...
Takeda Exits Cell Therapy Research to Refocus Pipeline Priorities
Japanese pharmaceutical giant Takeda announced the discontinuation of all cell therapy research activities, including platform technologies and clinical-stage programs, as part of a strategic...
Amgen’s PCSK9 Inhibitor Demonstrates Expanded Primary Prevention Benefits
Amgen presented landmark clinical trial data indicating its cholesterol-lowering drug Repatha reduces risk of major cardiovascular events in patients without prior cardiovascular disease. The...
Spatial Multiomics Tools and Software Propel Cancer and Disease Research
Researchers from Mount Sinai, Boston Medical Center, and Boston University unveiled Giotto Suite, an integrated software ecosystem designed to analyze complex spatial multiomics data, including...
AI-Driven Diagnostic and Drug Discovery Advances in Biopharma
Biopharmaceutical companies are harnessing AI to accelerate drug discovery and optimize diagnostics. A collaboration including AbbVie, Johnson & Johnson, Bristol Myers Squibb, Takeda, and Astex...
NIH and Academic Initiatives Push Pediatric and Rare Disease Research
Significant NIH funding supports novel pediatric research efforts including Pop Biotechnologies’ Alzheimer’s immunotherapy development and large-scale newborn genomic screening initiatives aimed...
Vanda Pharmaceuticals and FDA Resolve Legal Disputes Amid Drug Re-evaluations
Following protracted legal confrontations, Vanda Pharmaceuticals has agreed to withdraw or suspend multiple lawsuits against the FDA in return for re-examinations of two candidate treatments for...
Pfizer, Trump Reach Most-Favored Nation Drug Pricing Deal Amid Industry Adjustments
In a pivotal move, Pfizer has agreed to price newly launched drugs at parity with prices in comparable developed nations under a most-favored nation pricing agreement negotiated with the Trump...
Takeda Exits Cell Therapy Research to Refocus on Transformative Therapeutics
Japanese pharmaceutical giant Takeda has announced the discontinuation of all cell therapy research efforts as part of a strategic portfolio prioritization. The company plans to seek external...
Innovative AI Models Enhance Protein Design and Drug Discovery Collaborations
Recent breakthroughs reveal the use of advanced artificial intelligence models in protein engineering and drug discovery. Researchers at Integra Therapeutics, in partnership with academic...
Groundbreaking Spatial Proteomics and Multiomics Tools Propel Cancer and Disease Research
A suite of innovative spatial biology tools is revolutionizing how researchers visualize and analyze complex molecular landscapes within tissues. The Giotto Suite software facilitates integration...
Novel Diagnostic Advances with AI and Molecular Biomarkers for Cancer and Neurodegenerative Diseases
Recent studies demonstrate major advances in diagnostics aided by AI and molecular markers. Predicta Biosciences secured $23.4 million in Series A funding to expand its blood cancer and autoimmune...
Significant Progress in Radioligand Therapy and Immunotherapy for Prostate and Esophageal Cancer
Recent clinical advancements underscore growing momentum in cancer therapeutics. Research highlights the potential of radioligand therapy in metastatic prostate cancer, demonstrating novel...
New Gene Therapy and Molecular Targets Offer Hope in Neurological and Cancer Diseases
Innovative gene therapy and molecular research offer promising advancements across several disease domains. Paris-based biotech announced encouraging initial results from a gene therapy targeting...
Breakthroughs in Battery and Sustainable Energy Technologies from Novel Materials and Recycling
Researchers have unveiled key advances improving battery technologies and sustainable energy systems. Studies include development of engineered membranes for selective lithium extraction from...
US Government Shutdown Raises Concerns Over Science and Research Funding Stability
The US government shutdown commencing October 1, 2025, poses significant challenges for the scientific community. Key science agencies, including the NIH and NSF, have halted non-essential...
Amgen’s PCSK9 Drug Expands Cardiovascular Prevention
Amgen announced a landmark clinical trial demonstrating that its PCSK9 inhibitor, Repatha, significantly reduces the incidence of heart disease events in patients without prior cardiovascular...
Takeda Exits Cell Therapy Research Amid Strategic Shift
Japanese pharmaceutical giant Takeda announced it will discontinue all cell therapy research, a field once central to its genetic medicine strategy. This marks Takeda's full retreat from cell...